Sheldon Sloan

Chief Tech/Sci/R&D Officer at SPYRE THERAPEUTICS, INC.

Health Technology

Consumer Services

Profile

Sheldon Sloan is Chief Medical Officer at Spyre Therapeutics, Inc. since 2024.
Formerly, Chief Medical Officer at Abivax SA from 2023 to 2024.
Education includes graduate degree from the University of Pennsylvania, undergraduate degree from Illinois Urbana Champaign University of, and doctorate from Rush Medical College.

Sheldon Sloan active positions

Companies	Position	Start
SPYRE THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	01/10/2024

All active positions of Sheldon Sloan

Former positions of Sheldon Sloan

Companies	Position	End
ABIVAX	Chief Tech/Sci/R&D Officer	15/07/2024

See the detail of Sheldon Sloan's experience

Training of Sheldon Sloan

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sheldon Sloan's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Spyre Therapeutics, Inc. Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company	Health Technology
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Rush Medical College Rush Medical College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Abivax SA Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms	Health Technology